Literature DB >> 27827552

Alzheimer's disease: cerebrolysin and nanotechnology as a therapeutic strategy.

Hari S Sharma1, Dafin F Muresanu2,3, Aruna Sharma1.   

Abstract

Entities:  

Keywords:  Alzheimer's disease; AβP infusion; BBB leakage; brain pathology; cerebrolysin; diabetes; hypertension; military personnel; model; nanodelivery; neuroprotection; neurotrophic factors; post-traumatic stress disorder; traumatic brain injury

Mesh：

Substances：

Year:  2016        PMID： 27827552     DOI： 10.2217/nmt-2016-0037

Source DB:  PubMed          Journal:  Neurodegener Dis Manag        ISSN： 1758-2024


× No keyword cloud information.
  3 in total

1.  Co-Administration of TiO2 Nanowired Mesenchymal Stem Cells with Cerebrolysin Potentiates Neprilysin Level and Reduces Brain Pathology in Alzheimer's Disease.

Authors:  Hari Shanker Sharma; Dafin Fior Muresanu; José Vicente Lafuente; Ranjana Patnaik; Z Ryan Tian; Asya Ozkizilcik; Rudy J Castellani; Herbert Mössler; Aruna Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

2.  Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer's Disease.

Authors:  Ranjana Patnaik; Aruna Sharma; Stephen D Skaper; Dafin F Muresanu; José Vicente Lafuente; Rudy J Castellani; Ala Nozari; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

3.  CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer's disease.

Authors:  Zehui Liu; Wanyan Wang; Tingyu Huang; Cunfang Wang; Ying Huang; Yong Tang; Jin Huang
Journal:  PLoS One       Date:  2019-09-23       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.